![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter
Role of Radical Prostatectomy in the Management of Metastatic Prostate Cancer
Most of prostate cancers diagnosed at localized disease were regarded as less aggressive malignancy because of their indolent course; nonetheless, metastatic prostate cancer is still lethal. The 5-year surviva...
-
Article
Open AccessLymphovascular invasion have a similar prognostic value as lymph node involvement in patients undergoing radical cystectomy with urothelial carcinoma
To determine the prognostic value of lymphovascular invasion (LVI) in patients with bladder cancer who underwent radical cystectomy. Total of 747 patients underwent radical cystectomy; of these, only 164 did n...
-
Chapter
Multimodality Therapy
Trimodality therapy (TMT) for localized muscle-invasive bladder cancer (MIBC) is a substitute for radical cystectomy. TMT consists of chemoradiation and transurethral resection of bladder tumor (TURB). The pur...
-
Chapter
Radical Cystectomy
Bladder cancer is the fourth most common cancer in men in the United States. About 60,000 people develop each year. Bladder cancer is the eighth leading cause of cancer deaths in the United States. About 12,00...
-
Chapter
Treatment of Metastatic Bladder Cancer
Most bladder cancer patients present with noninvasive bladder cancer, but 20–40% of patients progress to advanced state with muscle-invasive or metastatic disease (Raghavan, Urol Oncol 21:468–474, 2003). In ge...
-
Article
Open AccessClinical outcomes of muscle invasive bladder Cancer according to the BASQ classification
We evaluated the clinical efficacy and prognosis of muscle-invasive bladder cancer according to the basal/squamous-like (BASQ) classification system based on immunohistochemical staining [CK5/6(+), CK14(+), GA...
-
Article
Open AccessPerioperative Safety and Efficacy of Holmium Laser Enucleation of the Prostate in Patients Receiving Antithrombotic Therapy: A Prospective Cohort Study
We investigated the efficacy of and risk from holmium laser enucleation of the prostate (HoLEP) due to discontinuation of antithrombotics in patients with benign prostatic hyperplasia (BPH). Patients in the pr...
-
Article
Open AccessThe number of metabolic features as a significant prognostic factor in patients with metastatic renal cell carcinoma
The effect of metabolic characteristics on the prognosis of patients with metastatic renal cell carcinoma remains controversial. We investigated the associations between metabolic features of each individual a...
-
Article
Open AccessThe effect of preoperative ureteral stenting in retrograde Intrarenal surgery: a multicenter, propensity score-matched study
Stent placement before retrograde intrarenal surgery (RIRS) can theoretically expand the ureter to improve access and remove stones. The purpose of this study was to investigate the effect of preoperative uret...
-
Article
Open AccessThe tumor volume after radical prostatectomy and its clinical impact on the prognosis of patients with localized prostate cancer
We evaluated the contribution of tumor volume (TV) to localized prostate cancer (PCa) patients’ prognosis. We retrospectively analyzed the data of 2394 patients who underwent radical prostatectomy (RP) for loc...
-
Article
Open AccessClinical determinants of recurrence in pTa bladder cancer following transurethral resection of bladder tumor
Non-muscle invasive bladder cancer can be controlled by transurethral resection of bladder (TURB), but suffers from frequent recurrences in 60–70% of cases. Although, recurrence interval after TURB influences ...
-
Article
Open AccessAssociation between decreased ipsilateral renal function and aggressive behavior in renal cell carcinoma
To assess prognostic value of pre-operative ipsilateral split renal function (SRF) on disease-free survival (DFS) and its association with aggressive pathological features in renal cell carcinoma (RCC) patients.
-
Article
Open AccessClinical features and Surgical Outcome of Clear Cell Papillary Renal Cell Tumor: result from a prospective cohort
Clear cell papillary renal cell tumor (CCPRCT) was first reported in 2006 a patient with end stage renal disease. After that it was discovered in the kidney without end stage renal disease in the 2010s and sta...
-
Article
Tubular damage marker as a predictive factor for pathologically upstaged renal cell carcinoma
To investigate if increased tubular damage biomarker can predict pathologically upstaged renal cell carcinoma (RCC), which may possess sub-radiologic invasive behavior, leading to surrounding tubular damage.
-
Article
Open AccessSurvival pattern of metastatic renal cell carcinoma patients according to WHO/ISUP grade: a long-term multi-institutional study
The World Health Organization/International Society of Urological Pathology (WHO/ISUP) grading of renal cell carcinoma (RCC) is classified from grade 1–4, regardless of subtype. The National Comprehensive Canc...